Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intraperitoneal chemotherapy in ovarian cancer remains experimental.

× No keyword cloud information.

14 in total

Review 1. Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting.

Authors: Antonio González-Martín; Gemma Toledo; Luis Chiva
Journal: Clin Transl Oncol Date: 2010-06 Impact factor: 3.405

2. Intraperitoneal chemotherapy for optimally debulked advanced ovarian cancer: a new standard in patient care?

Authors: A González Martín
Journal: Clin Transl Oncol Date: 2007-07 Impact factor: 3.405

Review 3. Latest research and treatment of advanced-stage epithelial ovarian cancer.

Authors: Robert L Coleman; Bradley J Monk; Anil K Sood; Thomas J Herzog
Journal: Nat Rev Clin Oncol Date: 2013-02-05 Impact factor: 66.675

4. Heterogeneity of tumor chemosensitivity in ovarian epithelial cancer revealed using the adenosine triphosphate-tumor chemosensitivity assay.

Authors: Jin Zhang; Hongxia Li
Journal: Oncol Lett Date: 2015-03-18 Impact factor: 2.967

5. Fatigue, Mood, and Sleep, During Intraperitoneal Chemotherapy: A Pilot Case Control Study.

Authors: Heather Jim; Anna Barata; Robert Wenham; Paul Jacobsen
Journal: Int J Psychol Res (Medellin) Date: 2013-06

6. Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.

Authors: H J Mackay; D Provencheur; M Heywood; D Tu; E A Eisenhauer; A M Oza; R Meyer
Journal: Curr Oncol Date: 2011-04 Impact factor: 3.677

7. Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer.

Authors: P Harter; S Mahner; F Hilpert; I Runnebaum; O Ortmann; A Mustea; J Sehouli; A du Bois; U Wagner
Journal: Geburtshilfe Frauenheilkd Date: 2013-03 Impact factor: 2.915

8. Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.

Authors: Bradley J Monk; Helen Q Huang; Robert A Burger; Robert S Mannel; Howard D Homesley; Jeffrey Fowler; Benjamin E Greer; Matthew Boente; Sharon X Liang; Lari Wenzel
Journal: Gynecol Oncol Date: 2012-12-04 Impact factor: 5.482

9. Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.

Authors: Mohammad H El-Dakdouki; Jingguang Xia; David C Zhu; Herbert Kavunja; Jessica Grieshaber; Sandra O'Reilly; J Justin McCormick; Xuefei Huang
Journal: ACS Appl Mater Interfaces Date: 2013-12-12 Impact factor: 9.229

10. Update in the management of ovarian and cervical carcinoma.

Authors: A Poveda; R Salazar; J M del Campo; C Mendiola; J Cassinello; B Ojeda; J A Arranz; A Oaknin; J García-Foncillas; M J Rubio; A González Martín
Journal: Clin Transl Oncol Date: 2007-07 Impact factor: 3.340